Clobenoside is a vasoprotective and anti-inflammatory agent. The drug was used for the topical treatment of chronic venous insufficiency and post-thrombotic syndrome. Clobenoside was also reportedly effective in treating traumatic edema through its inhibitory effects on histamine and/or kinins.

Sameridine was developed as a compound with both local anesthetic and opioid properties (partial micro-opioid receptor agonist). This drug participated in clinical trials when administered intrathecally to provide anesthesia for surgery and extended postoperative analgesia. However, further development of this drug was discontinued.

Brosotamide is organic compound useful as sedative, muscle-relaxing, antipyretic, choleretic, and analgesic agents

Pidolacetamol is an analgesic and antipyretic agent.

Xenbucin is an antihyperlipidemic agent. Information about the current use of this agent is not available.

Oxapadol (MD 720111), a non-narcotic analgesic that caused a significant increase in the threshold of the reflex whereas no change was noted with placebo. The current use of this drug is unknown.

Tribuzone is a non-steroidal anti-inflammatory drug (NSAID) that has been used to treat gout and Gilbert's syndrome. The usual adverse effects of NSAIDs have been observed with tribuzone, namely gastric effects, fluid retention and headache. Like other 3-oxoalkyl substituted diphenyldioxopyrazolidines it inhibits platelet aggregation.

Trifezolac is an ibufenac derivative. It is an analgesic, antipyretic, anti-inflammatory agent.

Famprofazone, a nonsteroidal anti-inflammatory agent, is found in a multi-ingredient medication (Gewodin) used for pain relief. It is available over-the-counter in Taiwan. Famprofazone transforms to methamphetamine (MA) and amphetamine (AM) following administration, which is responsible for the side effects of the drug. For example, famprofazone user might be interpreted as an illicit MA abuser in Taiwan because the user's urine tested positive for MA.